Trial
NCT05796271
Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
—
Condition
Lymphoma, B-Cell
Intervention
R-Chop and Roflumilast
Why stopped
Inadequate funding to begin enrolling subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-29